New technologies for the design and characterisation of nanotechnology mediated therapeutics | |||||
Tue4 Oct09:35am(45 mins)
|
|
Prof Molly Stevens | |||
Session : Keynote Presentation
Room: Auditorium 1
|
TBC | |||||
Tue4 Oct11:00am(30 mins)
|
![]() |
Dr John Bassett | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
Combining high throughput with high content for accelerating a more seamless screening process | |||||
Tue4 Oct11:30am(30 mins)
|
![]() |
Dr Suzanne Riches | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
Accelerating Drug Discovery with Cell Painting | |||||
Tue4 Oct12:00pm(30 mins)
|
![]() |
Mr James Pilling | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
Phenonaut; a tool for multiomic data integration, analysis, prediction, and inference | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Dr Steven Shave | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
TBC | |||||
Tue4 Oct02:30pm(5 mins)
|
![]() |
Alice Cheesbrough | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
TBC | |||||
Tue4 Oct02:35pm(30 mins)
|
![]() |
Dr Peter Horvath | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
Morphological trajectory inference: Tracking cell state transitions and the impact of small-molecule perturbations | |||||
Tue4 Oct03:45pm(30 mins)
|
![]() |
Dr Rebecca Hughes | |||
Session : High Content Imaging in Drug Discovery
Room: Auditorium 1
|
Genomic Sciences in Immunology – Strategies for Finding Future Drug Targets through Genetics, Functional Genomics and Immunophenotyping | |||||
Wed5 Oct09:05am(45 mins)
|
![]() |
Rabinder Prinjha | |||
Session : Keynote Presentation
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct11:00am(30 mins)
|
![]() |
Dr Benjamin Haibe-Kains | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
Developments in Cytometry Technology to Enhance Pre-Clinical Workflows: StarBright Dyes and the ZE5 Cell Analyzer | |||||
Wed5 Oct11:30am(30 mins)
|
![]() |
Dr Richard Cuthbert | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct12:00pm(30 mins)
|
![]() |
Mr Nathaniel Lam | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
Dr Mathew Garnett | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
New/Novel/Ground-breaking technologies assisting the sustainable preclinical drug discovery | |||||
Wed5 Oct02:30pm(5 mins)
|
![]() |
Dr Karthi RAJAMANI | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct02:35pm(5 mins)
|
![]() |
Dr Celine Legros | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
Upgrading African disease-in-a-dish models for pharmacovigilance: Enter the humble cell | |||||
Wed5 Oct02:40pm(30 mins)
|
![]() |
Dr Janine Scholefield | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct03:45pm(30 mins)
|
![]() |
Ms Elizabeth Hardaker | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Wed5 Oct04:15pm(30 mins)
|
![]() |
Prof Berend Snijder | |||
Session : Developments in Preclinical Models
Room: Auditorium 1
|
TBC | |||||
Tue4 Oct11:00am(30 mins)
|
|
Dr Robert Heald | |||
Room: Auditorium 2
|
The COVID Moonshot – from open science collaboration in fragment screening to drug candidate and beyond to Pandemic Preparedness | |||||
Tue4 Oct11:30am(30 mins)
|
![]() |
Dr Ed Griffen | |||
Room: Auditorium 2
|
TBC | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Sarah Skerrat | |||
Room: Auditorium 2
|
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery - Design tips and tricks | |||||
Tue4 Oct02:30pm(30 mins)
|
![]() |
Dr jamie scott | |||
Room: Auditorium 2
|
Targeting the template: A novel therapeutic strategy for prion diseases | |||||
Tue4 Oct03:45pm(30 mins)
|
![]() |
Dr Heulyn Jones | |||
Room: Auditorium 2
|
Navigate Your Chemistry And Explore The Biology - Case Studies Of CETSA® overcoming challenges in Drug Discovery | |||||
Tue4 Oct04:15pm(15 mins)
|
![]() |
Isabel Martin Caballero | |||
Room: Auditorium 2
|
TBC | |||||
Wed5 Oct11:00am(30 mins)
|
![]() |
Dr Barbara Domayne-Hayman | |||
Room: Auditorium 2
|
TBC | |||||
Wed5 Oct11:30am(30 mins)
|
![]() |
Dr Douglas Ross-Thriepland | |||
Room: Auditorium 2
|
Beyond Small Molecules… | |||||
Wed5 Oct12:00pm(15 mins)
|
![]() |
David Madge | |||
Room: Auditorium 2
|
The Drug Discovery Unit: Leading the development of new anti-infective treatments with a collaborative approach | |||||
Wed5 Oct02:00pm(30 mins)
|
![]() |
Dr Beatriz Baragana | |||
Room: Auditorium 2
|
Pressure over liquid – Established technology but with new value | |||||
Wed5 Oct02:30pm(5 mins)
|
![]() |
Paul Kendall | |||
Room: Auditorium 2
|
Dementia Drugs through Partnership at the ALBORADA Drug Discovery Institute | |||||
Wed5 Oct02:35pm(30 mins)
|
![]() |
Dr John Skidmore | |||
Room: Auditorium 2
|
The benefits of working side-by-side: The Crick-GSK Biomedical LinkLabs collaboration. | |||||
Wed5 Oct03:45pm(15 mins)
|
![]() |
Dr Katrin Rittinger |
![]() |
Dr Andrew Powell | |
Room: Auditorium 2
|
TBC | |||||
Wed5 Oct04:00pm(30 mins)
|
![]() |
Dr Martin Main | |||
Room: Auditorium 2
|
TBC | |||||
Tue4 Oct11:00am(30 mins)
|
![]() |
Dr Jo Brewer | |||
Session : Cell & Gene Therapy
Room: Auditorium 3
|
The journey from discovery to therapy begins with a single cell | |||||
Tue4 Oct11:30am(30 mins)
|
![]() |
Stephen Hague | |||
Session : Cell & Gene Therapy
Room: Auditorium 3
|
Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™ | |||||
Tue4 Oct12:00pm(5 mins)
|
![]() |
James Curtis | |||
Session : Cell & Gene Therapy
Room: Auditorium 3
|
Assist Plus Pipetting Platform | |||||
Tue4 Oct02:00pm(5 mins)
|
![]() |
Ms Sharon Barnard | |||
Session : Cell & Gene Therapy
Room: Auditorium 3
|
Automated analysis workflow to identify metal contamination in HTS outputs | |||||
Wed5 Oct11:00am(30 mins)
|
![]() |
Dr Rachel Moore | |||
Session : Advancements in Screening and Automation
Room: Auditorium 3
|
Multiparametric drug discovery facilitated by acoustic liquid handling | |||||
Wed5 Oct11:30am(15 mins)
|
![]() |
Mark Graham | |||
Session : Advancements in Screening and Automation
Room: Auditorium 3
|
HTS Assay detection at its best! - New PHERAstar FSX features improve data quality and sample processing | |||||
Wed5 Oct02:00pm(5 mins)
|
![]() |
Catherine Wark | |||
Session : Advancements in Screening and Automation
Room: Auditorium 3
|
TBC | |||||
Wed5 Oct03:45pm(30 mins)
|
|
Kirsten Tschapalda |
![]() |
Dr Federica Morandi | |
Session : Advancements in Screening and Automation
Room: Auditorium 3
|
Collaborative AMR Implementation in Biopharmaceutical Labs | |||||
Wed5 Oct04:15pm(30 mins)
|
![]() |
Mr Thomas Albanetti | |||
Session : Advancements in Screening and Automation
Room: Auditorium 3
|
TBC | |||||
Tue4 Oct11:00am(30 mins)
|
![]() |
Prof Wisia Wedzicha | |||
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
Novel drug targets in COPD | |||||
Tue4 Oct11:30am(30 mins)
|
![]() |
Prof Ian Adcock | |||
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
New perspectives for modelling inflammatory diseases using patient-derived organoids | |||||
Tue4 Oct12:00pm(5 mins)
|
![]() |
Dr Sylvia F. Boj | |||
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
TBC | |||||
Tue4 Oct02:00pm(30 mins)
|
![]() |
Dr Anna Morgan | |||
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
TBC | |||||
Wed5 Oct11:00am(30 mins)
|
![]() |
Prof Ali Tavassoli | |||
Room: Auditorium 4
|
Oxford Nanopore Technologies - a look into the complete genome | |||||
Wed5 Oct11:30am(15 mins)
|
![]() |
Daniel Fordham | |||
Room: Auditorium 4
|
TBC | |||||
Wed5 Oct11:45am(30 mins)
|
![]() |
Mrs Catherine Alder | |||
Room: Auditorium 4
|